Ciloxan (ciprofloxacin hydrochloride) NDC 66758-071

NDC codes

FDA NDC Directory

Product NDC (as listed)66758-071Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66758-0071Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66758-071-38	66758007138	3.5 g in 1 TUBE (66758-071-38)Marketed from Mar 28, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ciloxan
Generic name (nonproprietary): ciprofloxacin hydrochloride
Active ingredients: Ciprofloxacin hydrochloride — 3 mg/g
Dosage form: Ointment
Route: Ophthalmic
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020369
Marketing start: Jun 2, 1998
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Fluoroquinolones (Chemical structure)
Identifiers: Product ID 66758-071_930a2e4b-dcac-4a27-a073-fd21622c1666SPL ID 930a2e4b-dcac-4a27-a073-fd21622c1666SPL set ID 09ca5374-2a16-4a95-91b3-70591d78254eRxCUI 213307, 309306UNII 4BA73M5E37UPC 0366758071380
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466758007138 followed by a unit qualifier and the quantity

Package 66758-0071-38. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 30, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE: CILOXAN ® (ciprofloxacin ophthalmic ointment) 0.3% is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the microorganisms listed below: Gram-Positive: Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus Viridans Group Gram-Negative: Haemophilus influenzae

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)